CYXO.ST

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Biotechnology

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E	# Analysts
2026	$2M	-29.9%	$-0.16	$-0.16–$-0.16	—	1

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
CYXO.STCyxone AB (publ)	$0.02	+0.00%	$7M	—
ASAP.STAsarina Pharma AB (publ)	$0.03	-31.03%	$633959	—
BONZUN.STBonzun AB (publ)	$0.01	+0.00%	$7M	—
CLINE-B.STCline Scientific AB (publ)	$0.07	+0.00%	$3M	—
DEAR.STDuearity AB (publ)	$0.02	+0.00%	$3M	—
HEMC.STHemcheck Sweden AB (publ)	$0.23	+26.11%	$9M	—
IDOGEN.STIdogen AB (publ)	$0.12	-2.82%	$13M	—

Source: Financial Modeling Prep · peers by sector/industry

Cyxone AB (publ)

Cyxone AB (publ) is a clinical-stage biotechnology firm focused on developing innovative, disease-modifying therapies. Its primary therapeutic targets include rheumatoid arthritis, multiple sclerosis, and acute respiratory illnesses caused by viruses. The company's pipeline features Rabeximod, currently in Phase II clinical trials for both rheumatoid arthritis and COVID-19. Additionally, T20K, a drug candidate for multiple sclerosis, is undergoing Phase 1 evaluation. Established in 2015, the company is headquartered in Malmö, Sweden.

www.cyxone.com

Employees: 3
IPO / List date: Jun 7, 2016
HQ: SE

Held by traders on TradeandTell

No one on the platform currently holds CYXO.ST.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in CYXO.ST as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded CYXO.ST yet.